Executive readout · one minute
Call research workspace
Read the call alongside every captured source. Audio, transcript, slides and SEC filings stay in one workspace.
GALT
$3.44
-2.55%
GALT · Galectin Therapeutics Inc
$3.44
-0.09 (-2.55%)
At close · Aug 14
Going-concern doubt
— flagged Aug 14, 2026
Substantial doubt about the company's ability to continue as a going concern.
“These factors raise substantial doubt about the Company's ability to continue as a going concern for a period of 12 months from the issuance date of these financial statements.”View the 10-Q filed Aug 14, 2026
Market Cap
$346.92M
Shares
100.85M
All earnings calls
Earnings call · FY2025 Q2
Galectin Therapeutics Inc Q2 FY2025 Earnings Call
Galectin Therapeutics Inc Q2 FY2025 Earnings Call
Research coverage
2 live sources
Switch sources without leaving this page or losing your listening position.
Diluted EPS
-$0.12
Net income
-$7.52M
Research materials
Open the source you need; every reader stays inside this workspace.
SEC filing · Item 2.02
8-K earnings release
Filed Aug 14, 2025 · complete as-filed document
SEC periodic report
10-Q report
Filed Aug 14, 2025 · complete as-filed document